Blar i Bergen Open Research Archive på forfatter "Nesvåg, Sverre"
-
Assessment of executive function in patients with substance use disorder: A comparison of inventory- and performance-based assessment
Hagen, Egon; Erga, Aleksander Hagen; Hagen, Katrin Pedersen; Nesvåg, Sverre; McKay, James R.; Lundervold, Astri; Walderhaug, Espen (Peer reviewed; Journal article, 2016-07)Introduction Chronic polysubstance abuse (SUD) is associated with neurophysiological and neuroanatomical changes. Neurocognitive impairment tends to affect quality of life, occupational functioning, and the ability to ... -
One-year abstinence improves ADHD symptoms among patients with polysubstance use disorder
Hagen, Egon; Erga, Aleksander Hagen; Nesvåg, Sverre; McKay, James R.; Lundervold, Astri; Walderhaug, Espen (Peer reviewed; Journal article, 2017-12)Introduction Attention-deficit/hyperactivity disorder (ADHD) is a common comorbid disorder in patients suffering from substance use disorder (SUD). Individuals with co-occurring SUD and ADHD are more likely than SUD patients ... -
One-year sobriety improves satisfaction with life, executive functions and psychological distress among patients with polysubstance use disorder
Hagen, Egon; Erga, Aleksander Hagen; Hagen, Katrin Pedersen; Nesvåg, Sverre; McKay, James R.; Astri, Lundervold; Walderhaug, Espen (Peer reviewed; Journal article, 2017-05)Introduction: Polysubstance use disorder is prevalent in treatment-seeking patients with substance use disorder (SUD), with a higher risk of developing comorbid psychiatric symptoms, more pervasive deficits in cognitive ... -
Securing Participant Engagement in Longitudinal Substance Use Disorder Recovery Research: A Qualitative Exploration of Key Retention Factors
Svendsen, Thomas Solgaard; Veseth, Marius; McKay, James R.; Bjornestad, Jone; Erga, Aleksander Hagen; Moltu, Christian; Nesvåg, Sverre (Journal article; Peer reviewed, 2021)The longitudinal cohort study is the gold standard in observational epidemiology. A central challenge with this design is the risk of attrition over time, especially in studies of inaccessible clinical populations, such ...